Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Print


Guest: Welcome to ChinaBio
® Today!

As a guest to ChinaBio® Today, you have access to summaries of over 3000 articles including our archives.  You can use the Search feature on the left menu bar to find what you're looking for, or you can browse summaries of our articles by the categories listed under Subscriber Articles. You can access any article that is marked as FREE. Or you can subscribe and have access to our entire content.   

Top Stories

>> See all top stories...


Recent Articles

Recent Articles

  China's Yueda Forms China Renal Care Clinic JV with Diaverum (in: Deals & Financings)
  Fosun Pharma to Pay $1.4 Billion for India's Gland Pharma in Historic Deal (in: Deals & Financings)
  CR Sanjiu Pharma Acquires Shenghuo Pharma for $280 Million (in: Deals & Financings)
  Luye Pharma to Acquire Swiss Patch Drug Assets for $269 Million (in: Deals & Financings)
  World Bank Report: China Must Reform its Healthcare Delivery (in: Gov't & Regulatory)
  Aspen Pharma Building China Presence for its Generic Drug Portfolio (in: News & Analysis)
  Week in Review: Cross-Border Investments Rule the News (in: Week in Review)
  Jilin Zixin Pharma to Pay $42 Million for Majority Stake in US Genome Mapping Company (in: Deals & Financings)
  China to Test CRISPR-Edited Cells in Lung Cancer (in: Trials & Approvals)
  Sinopharm Revises Plan to Reform its State-Owned Enterprise Structure (in: News & Analysis)
 
Login

  

    
   
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors